Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery

Journal of Microencapsulation

Volumn 20, Issue 3, 2003, Pages 361-374

  De, T K ^a   Rodman, D J ^a   Holm, B A ^a   Prasad, P N ^a   Bergey, E J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Brimonidine; Mucosal delivery; Nanoparticles; Polyacrylic acid; Reverse microemulsion

Indexed keywords

BETAXOLOL; BRIMONIDINE; NANOPARTICLE; POLYACRYLIC ACID; TIMOLOL;

ARTICLE; CELL STRAIN CACO 2; CELL VIABILITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; INTRAOCULAR PRESSURE; LASER MICROSCOPY; MICROEMULSION; PARTICLE SIZE; PH; POLYMERIZATION;

ACRYLIC RESINS; ANTIHYPERTENSIVE AGENTS; BIOCOMPATIBLE MATERIALS; CACO-2 CELLS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; HUMANS; MICROSCOPY, CONFOCAL; MICROSPHERES; NANOTECHNOLOGY; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; QUINOXALINES;

EID: 0038784391     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/0265204031000093591     Document Type: Article

References (54)

1. AHUJA, A., Khar, R. K. and ALI, J., 1997, Mucoadhesive drug delivery systems. Drug Development and Industrial Pharmacy, 23, 489-515.
2. AL-MANSOURI, S., TABBARA, K. F. and RASK-PEDERSEN, E., 1994, Lubrithal (Leo viscous eye gel), precorneal residence time in normal and dry eyes. Documenta Ophthalmologica. Advances in Ophthalmology, 88, 187-194.
3. ARTURSSON, P., 1991, Cell cultures as models for drug absorption across the intestinal mucosa. Critical Reviews in Therapeutic Drug Carrier Systems, 8, 305-330.
4. ARTURSSON, P. and KARLSSON, J., 1991, Correlation between oral absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cell culture. Biochemical and Biophysical Research Communications, 175, 880-885.
5. BLANCO-FUENTE, H., ANGUIANOLGEA, S., OTEROESPINAR, F. J. and BLANCOMENDEZ, J., 1996, In vitro bioadhesion of carbopol hydrogels. International Journal of Pharmaceutics, 142, 169-174.
6. BURKE, J. and SCHWARTZ, M., 1996, Preclinical evaluation of brimonidine. Survey of Ophthalmology, 41, S9-S18.
7. 2-Adrenergic Receptors: Structure, Function and Therapeutic Implications, edited by S. Lanier and L. Limbird (Reading, UK: Harwood Academic Publishers), pp. 179-187.
8. CALVO, P., ALONSO, M. J., VILA-JATO, J. L. and ROBINSON, J. R., 1996a, Improved ocular bioavailability of indomethacin by novel ocular drug carriers. The Journal of Pharmacy and Pharmacology, 48, 1147-1152.
9. CALVO, P., VILA-JATO, J. L. and ALONSO, M. J., 1996b, Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. Journal of Pharmaceutical Scieces, 85, 530-536.
10. CANTOR, B. L. and BURKE, J., 1997, Drug evaluation: brimonidine. Expert Opinion in Investigational Drugs, 6, 1063-1083.
11. CHEN, Y. F., HUNG, P. T., HSIEH, J. W., SHEIN, J. and HSIAO, C. K., 2002, The efficacy of brimonidine in preventing intraocular pressure elevation in the provocative test for primary angle-closure glaucoma. Journal of Ocular Pharmacology and Therapeutics, 18, 99-103.
12. DE, T. K. and HOFFMAN, A. S., 2001a, A reverse microemulsion polymerization method for preparation of bioadhesive polyacrylic acid nanoparticles for mucosal drug delivery: loading and release of timolol maleate. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 29, 31-46.
13. DE, T. K. and HOFFMAN, A. S., 2001b, An ophthalmic formulation of a β-adrenoceptor antagonist, levobetaxolol, using polyacrylic acid nanoparticles as carrier: loading and release studies. Journal of Bioactive and Compatible Polymers, 16, 20-31.
14. DERICK, R. J., ROBIN, A. L., WALTERS, T. R., BARNEBEY, H. S., CHOPLIN, N., SCHUMAN, J., KELLEY, E. P., CHEN, K. and STOECKER, J. F., 1997, Brimonidine tartrate: a one-month dose response study. Ophthalmology, 104, 131-136.
15. DIEBOLD, Y., HERRERAS, J. M., CALLEJO, S., ARGUESO, P. and CALONGE, M., 1998, Carbomer-versus cellulose-based artificial-tear formulations; morphologic and toxicological effects on a corneal cell line. Cornea, 17, 433-440.
16. GENTA, I., CONTI, B., PERUGINI, P., PAVANETTO, F., SPADARO, A. and PUGLISI, G., 1997, Bioadhesive microspheres for ophthalmic administration of acyclovir. The Journal of Pharmacy and Pharmacology, 49, 737-742.
17. GU, J. M., ROBINSON, J. R. and LEUNG, S. H. S., 1988, Binding of acrylic polymers to mucin/epithelial surface: structure property relationship. Critical Reviews in Therapeutic Drug Carrier Systems, 5, 21-67.
18. HARMIA, T., SPEISER, P. and KREUTER, J., 1986, Optimization of pilocarpine loading onto nanoparticles by sorption procedures. International Journal of Pharmaceutics, 33, 45-54.
19. HIDALGO, I. J., RAUB, T. J. and BORCHARDT, R. T., 1989, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736-749.
20. JANI, R., GAN, O., ALI, Y., RODSTORM, R. and HANCOCK, S., 1994, Ion exchange resins for ophthalmic delivery. Journal of Ocular Pharmacology, 10, 57-67.
21. JONES, D. S., WOOLFSON, A. D. and BROWN, A. F., 1997, Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. International Journal of Pharmaceutics, 15, 223-233.
22. KATZ, L. J., 1999, Brimonidine tartrate 0.2% twice-daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. American Journal of Ophthalmology, 127, 20-26.
23. KRIWET, B. and KISSEL, T., 1996, Poly(acrylic acid) microparticles widen the intercellular spaces of Caco-2 cell monolayers: an examination by confocal laser scanning microscopy. European Journal of Pharmaceutics and Biopharmaceutics, 42, 233-240.
24. LAFUENTE, M. P., VILLEGAS-PEREZ, M. P., MAYOR, S., AGUILERA, M. E., MIRALLES, I. J. and VIDAL-SANZ, M., 2002, Neuroprotective effects of brimonidine against ischemia-induced retinal ganglion. Cell death: a dose response in vivo study. Experimental Eye Research, 74, 181-189.
25. LAI, R., HASSAN, D. and CHUN, T., 1997, Neuroprotective effect of ocular hypotensive agent brimonidine, Xith Congress of the European Society of Ophthalmology, Budapest, 439-444.
26. LANGER, K., STIENKER, F., LAMBRECHT, G., MUTSCHLER, E. and KREUTER, J., 1997, Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery, Part II: arecaidine propargyl ester and pilocarpine loading and in vitro release. International Journal of Pharmaceutics, 158, 211-217.
27. LAROCHE, L., ARRATA, M., BRASSEUR, G., LAGOUTTE, F., LE, M. Y., LUMBROSO, P., MERCANTE, M., NORMAND, F., RIGAL, D. and RONCON, S., 1991, Treatment of dry eye syndrome with lacrimal gel: a randomized multicenter study. Journal Francais d'Ophtalmologie, 14, 321-326.
28. LEBLAMC, R. P., 1998, Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Ophthalmology, 105, 1960-1967.
29. LEE, V. H. L. and ROBINSON, J. R., 1979, Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. Journal of Pharmaceutical Sciences, 68, 673-684.
30. LEHR, C. M., LEE, Y. H. and LEE, V. H., 1994, Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit. Investigative Ophthalmology & Visual Science, 35, 2809-2814.
31. LOSA, C., CALVO, P., CASTRO, E., VILA-JATO, J. L. and ALONSO, M. J., 1991, Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. The Journal of Pharmacy and Pharmacology, 43, 548-552.
32. LUESSEN, H. L., BOHNER, V., PERARD, D., LANGGUTH, P., VERHOEF, J. C., BOER, A. G., MERKLE, H. P. and JUNGINGER, H. E., 1996a, Mucoadhesive polymers in peroral peptide drug delivery. V. Effect of poly(acrylates) on enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles. International Journal of Pharmaceutics, 141, 117-128.
33. LUESSEN, H. L., BORCHARD, G., VERHOEF, J. C., LEHR, C. M., BOER, A. G. and JUNGINGER, H. E., 1995, Mucoadhesive polymers in peroral peptide delivery. II. Carbomer® and Polycarbophil® are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharmaceutical Research, 12, 1293-1298.
34. LUESSEN, H. L., RENTEL, C. O., KOTZE, A. F., LEHR, C. M., BOER, A. G., VERHOEF, J. C. and JUNGINGER, H. E., 1997, Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil® and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. Journal of Controlled Release, 45, 15-23.
35. LUESSEN, H. L., LEEUW, B. J., PERARD, D., LEHR, C. M., BOER, A. G., VERHOEF, J. C. and JUNGINGER, H. E., 1996b, Mucoadhesive polymers in peroral peptide drug delivery. I. Influence of mucoadhesive excipents on the proteolytic activity of intestinal enzymes. European Journal of Pharmaceutical Sciences, 4, 117-128.
36. MARNER, K., MOLLER, P. M., DILLON, M. and RASK-PEDERSON, E., 1996, Viscous carbomer eye drops in patients with dry eyes: efficacy and safety: a randomized, open, cross-over, multicentre study. Acta Ophthalmologica Scandinavica, 74, 249-252.
37. MELAMED, S. and DAVID, R., 2000, Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results. Clinical Therapeutics, 22, 103-111.
38. 2-adrenoceptor activity. Bioorganic & Medicinal Chemistry Letters, 5, 1745.
39. NORDLUND, J. R., PASQUALE, L. R., ROBIN, A. L., RUDIKOFF, M. T., ORDMAN, J., CHEN, K. S. and WALT, J., 1995, The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine. Archivies of Ophthalmology, 113, 77-83.
40. PARK, H. and ROBINSON, J. R., 1987, Mechanism of mucoadhesion of poly(acrylic acid) hydrogels. Pharmaceutical Research, 4, 457-464.
41. PATTON, T. F. and ROBINSON, J. R., 1976, Quantitative precorneal disposition of topical applied pilocarpine nitrate in rabbit eyes. Journal of Pharmaceutical Sciences, 65, 1295-1301.
42. PEPPAS, N. A. and SAHLIN, J. J., 1996, Hydrogels mucoadhesive and bioadhesive materials - a review. Biomaterials, 17, 1533-1561.
43. ROSENTHAL, A. L., WALTERS, T. and BERG, E., 1996, A comparison of the safety and efficacy of brimonidine 0.2%. BID versus TID in subjects with elevated intraocular pressure. Investigative Ophthalmology & Visual Science, 37, S1102.
44. SCHUMAN, J. S., 1996, Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Survey of Ophthalmology, 41, 27-37.
45. SCHUMAN, J. S., HORWITZ, B., CHOPLIN, N. T., DAVID, R., ALBRACHT, D. and CHEN, K., 1997, A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic brimonidine study group. Archives of Ophthalmology, 115, 847-852.
46. SERLE, J. B., 1996, A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial] Survey of Ophthalmology, 41, Suppl 1:S39-47.
47. SHOJAEI, A. H. and LI, X. L., 1997, Mechanisms of buccal mucoadhesion of novel copolymers of acrylic acid and polyethylene glycol monomethylether monomethacrylate. Journal of Controlled Release, 47, 151-161.
48. TAKEUCHI, H., YAMAMOTO, H. and KAWASHIMA, Y., 2001, Mucoadhesive nanoparticulate systems for peptide drug delivery. Advances in Drug Delivery Reviews, 47, 39-54.
49. THERMES, F., GROVE, J., ROZIER, A., PLAZONNET, B., CONSTANCIS, A., BUNEL, C. and VAIRON, J. P., 1992a, Mucoadhesion of copolymers and mixtures containing polyacrylic acid. Pharmaceutical Research, 9, 1563-1567.
50. THERMES, F., ROZIER, A., PLAZONNET, B. and GROVE, J., 1992b, Bioadhesion: the effect of poly(acrylic acid) on the ocular bioavailability of timolol. International Journal of Pharmaceutics, 81, 59-65.
51. TORRIS, C. B., CAMRAS, C. B. and YABLONSKI, M. E., 1999, Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. American Journal of Ophthalmology, 128, 8-14.
52. TUR, K. M. and CHANG, H. S., 1998, Evaluation of possible mechanism(s) of bioadhesion. International Journal of Pharmaceutics, 1, 61-74.
53. WALLIEKE, P. A., 1988, Basic and acidic fibroblast growth factors have tropic effect on neurons from multiple CNS regions. Journal of Neuroscience, 8, 2618-2627.
54. ZIMMER, A., MUTSHLER, E., LAMBRECHT, G., MAYER, D. and KREUTER, J., 1994, Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system. Pharmaceutical Research, 11, 1435-1442.